Your browser doesn't support javascript.
loading
Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST.
Goldmacher, Gregory V; Khilnani, Anuradha D; Andtbacka, Robert H I; Luke, Jason J; Hodi, F Stephen; Marabelle, Aurelien; Harrington, Kevin; Perrone, Andrea; Tse, Archie; Madoff, David C; Schwartz, Lawrence H.
Afiliação
  • Goldmacher GV; Merck & Co., Inc., Kenilworth, NJ.
  • Khilnani AD; Merck & Co., Inc., Kenilworth, NJ.
  • Andtbacka RHI; Seven and Eight Biopharmaceuticals, Edison, NJ.
  • Luke JJ; University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.
  • Hodi FS; Dana-Farber Cancer Institute, Boston, MA.
  • Marabelle A; INSERM CIC BT 1428 Gustave Roussy, University of Paris-Saclay, Villejuif, France.
  • Harrington K; The Royal Marsden/The Institute of Cancer Research NIHR Biomedical Research Centre, London, United Kingdom.
  • Perrone A; Merck & Co., Inc., Kenilworth, NJ.
  • Tse A; CStone Pharmaceuticals, Suzhou, China.
  • Madoff DC; Smilow Cancer Hospital, Yale Cancer Center, Yale School of Medicine, New Haven, CT.
  • Schwartz LH; New York-Presbyterian Hospital, Columbia University College of Physicians and Surgeons, New York, NY.
J Clin Oncol ; 38(23): 2667-2676, 2020 08 10.
Article em En | MEDLINE | ID: mdl-32552274
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article